Moreover, CNS GIPR KO and mGIPR-Ab/GLP-1 treatment of wild-type mice both result in reduced activity in pathways associated with immune function, particularly neutrophil degranulation, suggesting that decreased CNS GIPR signalling might reduce obesity-associated inflammation 47,48,49
In traditional clinical trials, a "responder" is someone who loses at least 5% of their body weight within the first three to six months
Oxidative stress biomarkers (MDA, 8-isoprostane, GSSG/GSH ratio) show your baseline antioxidant burden
10.1016/j.ceb.2007.08.002 Curr
The issue is what happens when genuine interest in better energy, faster recovery, improved body composition, and higher quality of life gets met with hype instead of clinical guidance
Not as a standalone intervention